Annual CFI
N/A
31 December 2023
Summary:
Revelation Biosciences annual cash flow from investing activities is not available.REVBW Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$17.69 K
-$17.69 K-100.00%
30 September 2024
Summary:
Revelation Biosciences quarterly cash flow from investing activities is currently -$17.69 thousand, with the most recent change of -$17.69 thousand (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$17.69 thousand (-100.00%). REVBW quarterly CFI is now -209.50% below its all-time high of $16.15 thousand, reached on 31 December 2021.REVBW Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$36.86 K
-$17.69 K-92.26%
30 September 2024
Summary:
Revelation Biosciences TTM cash flow from investing activities is currently -$36.86 thousand, with the most recent change of -$17.69 thousand (-92.26%) on 30 September 2024. Over the past year, it has dropped by -$36.86 thousand (-100.00%). REVBW TTM CFI is now -328.19% below its all-time high of $16.15 thousand, reached on 30 June 2022.REVBW TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVBW Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -100.0% | -100.0% |
| 3 y3 years | - | -100.0% | +75.1% |
| 5 y5 years | - | - | - |
REVBW Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -209.5% | +7.7% | -328.2% | +75.1% | ||
| 5 y | 5 years | -209.5% | +82.2% | -328.2% | +75.1% | ||
| alltime | all time | -209.5% | +82.2% | -328.2% | +75.1% |
Revelation Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.69 K(<-9900.0%) | -$36.86 K(+92.3%) |
| June 2024 | - | $0.00(-100.0%) | -$19.17 K(0.0%) |
| Mar 2024 | - | -$19.17 K(<-9900.0%) | -$19.17 K(<-9900.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | $0.00 | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $0.00(0.0%) | $16.15 K(-149.2%) |
| Mar 2022 | - | $0.00(-100.0%) | -$32.86 K(-75.1%) |
| Dec 2021 | -$131.96 K | $16.15 K(>+9900.0%) | -$131.96 K(-10.9%) |
| Sept 2021 | - | $0.00(-100.0%) | -$148.12 K(0.0%) |
| June 2021 | - | -$49.02 K(-50.5%) | -$148.12 K(+49.5%) |
| Mar 2021 | - | -$99.10 K | -$99.10 K |
FAQ
- What is the all time high annual CFI for Revelation Biosciences?
- What is Revelation Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Revelation Biosciences?
- What is Revelation Biosciences quarterly CFI year-on-year change?
- What is Revelation Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Revelation Biosciences?
- What is Revelation Biosciences TTM CFI year-on-year change?
What is the all time high annual CFI for Revelation Biosciences?
Revelation Biosciences all-time high annual cash flow from investing activities is $0.00
What is Revelation Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of REVBW is -$17.69 K
What is the all time high quarterly CFI for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash flow from investing activities is $16.15 K
What is Revelation Biosciences quarterly CFI year-on-year change?
Over the past year, REVBW quarterly cash flow from investing activities has changed by -$17.69 K (-100.00%)
What is Revelation Biosciences TTM cash flow from investing activities?
The current TTM CFI of REVBW is -$36.86 K
What is the all time high TTM CFI for Revelation Biosciences?
Revelation Biosciences all-time high TTM cash flow from investing activities is $16.15 K
What is Revelation Biosciences TTM CFI year-on-year change?
Over the past year, REVBW TTM cash flow from investing activities has changed by -$36.86 K (-100.00%)